Contact this trialFirst, we need to learn more about you.
ATR Inhibitor
BAY 1895344 + FOLFIRI for Stomach and Intestinal Cancer
Recruiting1 awardPhase 1
Saint Peters, Missouri
This trial is testing a combination of drugs to treat stomach or intestinal cancer. The first drug, BAY 1895344, may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. The second drug, a chemotherapy drug called FOLFIRI, works in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial is testing to see if the combination of these two drugs may help shrink advanced or metastatic stomach and/or intestinal cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service